3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
6
Gastro-enteropancreatic neuroendocrine tumor
2
Urogenital Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Prostatic Diseases
1
Prostate Cancer Metastatic
1
Pheochromocytoma
1
Paraganglioma
1
Neuroendocrine Tumors
1
Metastatic Neuroendocrine Prostate Cancer
1
Metastatic Castration-resistant Prostate Cancer (mCRPC)
1
Metastatic Castration-Resistant Prostate Cancer
1
Metastatic Castration Resistant Prostate Cancer (mCRPC)
1
Lung Neoplasms
1
Digestive System Neoplasms
1
Breast Neoplasms
1
Advanced Gastroenteropancreatic Neuroendocrine Tumor
1
Interventions
fludarabine
5
Cyclophosphamide
5
fludarabine phosphate
4
Whole-Body Irradiation
2
Tacrolimus
2
Peripheral Blood Stem Cell Transplantation
2
Patient Reported Outcome Measures
2
Mycophenolic Acid
2
Mesna
2
Melphalan
2
Busulfan
2
Bendamustine Hydrochloride
2
AP 1903 reagent
2
pembrolizumab
1
isatuximab
1
ibrutinib
1
Lenalidomide
1
Dexamethasone
1
CLR1404
1
CA-4948
1
Bortezomib
1
Bone Marrow Transplantation
1
ARQ531
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Immunoproliferative Disorders
×
Lutetium
×
1 year
×
Clear all
No trials found.